Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, July 29, 2025 · 835,191,982 Articles · 3+ Million Readers

Enovation in IOL Material: VSY Biotechnology’s Enova® Premium IOLs Set New Standard with 100% Glistening Free Technology

Enova IOL

Enova IOL

LEINFELDEN-ECHTERDINGEN, GERMANY, July 29, 2025 /EINPresswire.com/ -- VSY Biotechnology GmbH’s groundbreaking Enova® intraocular lens is reshaping expectations in the ophthalmic industry. As the first and only 100% glistening-free hydrophobic acrylic IOL that requires no prehydration or saline storage, Enova® Premium IOLs reflect the company’s commitment to continuous innovation, what it calls "Enovation in IOL Material."

Designed with a unique material composition, Enova® enables uniform hydration at specific molecular sites, offering controlled water uptake and full resistance to glistening formation. Compared to other hydrophobic IOLs on the market that typically develop mild to moderate glistening over time, Enova® demonstrated no glistening formation, enabled by the unique composition of Enova® material. These features address one of the most persistent challenges in IOL technology, glistening-related optical degradation. The lens is also dry-packed, simplifying storage and surgical workflow while maintaining superior optical clarity and mechanical stability.

The Enova® family comprises multiple IOL designs tailored to diverse patient needs, including Monofocal PGF3, EDOF Advanced, and the Sinusoidal IOL Maestro. Each model benefits from the same glistening free material innovation, delivering consistent optical performance across the entire portfolio.

Validated by in vitro studies from the University of Utah’s Intermountain Ocular Research Center (Mamalis/Werner Laboratory), Enova® demonstrated no glistening formation under stress conditions. In comparison, other leading hydrophobic acrylic IOLs showed mild to moderate glistening. This confirmed Enova® as a top-tier choice for visual performance and long-term patient outcomes.

Beyond its optical clarity, Enova® features a low glass transition temperature (Tg -2°C), ensuring gentle and controlled unfolding at room temperature without warming or special handling. Its biomechanical balance, achieved through an optimized modulus of elasticity, supports precise surgical delivery and excellent postoperative results.

With Enova®, VSY Biotechnology GmbH once again proves its leadership in the IOL space, setting a new global benchmark for glistening-free performance, backed by science, innovation, and the spirit of true Enovation.

Christian Bach
VSY Biotechnology GmbH
email us here

Powered by EIN Presswire

Distribution channels: Business & Economy, Chemical Industry, Companies, Healthcare & Pharmaceuticals Industry, Science

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release